Evidence based cardiology. Prevention of ischaemic stroke

British Medical Journal

Volumn 318, Issue 7197, 1999, Pages 1539-1543

  Barnett, Henry J M ^a   Eliasziw, Michael ^a   Meldrum, Heather E ^a  

^a Institute of Cancer Research   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; WARFARIN;

CARDIOLOGY; CAROTID ARTERY OBSTRUCTION; DISEASE SEVERITY; ENDARTERECTOMY; EVIDENCE BASED MEDICINE; HEALTH CARE DELIVERY; HEART ATRIUM FIBRILLATION; HUMAN; HYPERGLYCEMIA; HYPERTENSION; PRIORITY JOURNAL; RISK FACTOR; SHORT SURVEY; SMOKING; STROKE;

EID: 0032988881     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (45)

1. 1 Murray CJL, Lopez AD. Mortality by cause for eight regions of the world: global burden of disease study. Lancet 1997;349:1269-76.
2. 2 Barnett HJM, Meldrum HE, Eliasziw M. The prevention of ischaemic stroke. In: Yusuf S, Cairns JA, Camm AJ, Fallen EL, Gersh BJ, eds. Evidence based cardiology. London: BMJ Books 1998:992-1008.
3. 3 Hebert PR, Gaziano JM, Chan KS, Hennekens CH. Cholesterol lowering with statin drugs, risk of stroke, and total mortality. An overview of randomized trials. JAMA 1997;278:313-21.
4. 4 Wolf PA. Epidemiology and risk factor management. In: Welch KMA, Caplan LR, Reis DJ, Siesjö BK, Weir B, eds. Primer on cerebrovascular diseases. San Diego: Academic Press, 1997:751-7.
5. 5 Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86.
6. 6 Refsum H, Ueland PM, Nygard O, Vollset SE. Homocysteine and cardiovascular disease. Annu Rev Med 1998;49:31-62.
7. 7 Stroke Prevention in Atrial Fibrillation Investigators. Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: stroke prevention in atrial fibrillation II study. Lancet 1994;343:687-91.
8. 8 SPAF III Writing Committee for the Stroke Prevention in Atrial Fibrillation Investigators. Patients with nonvalvular atrial fibrillation at low risk of stroke during treatment with aspirin. JAMA 1998;279:1273-7.
9. 9 Stroke Prevention in Atrial Fibrillation Investigators. Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: stroke prevention in atrial fibrillation III randomized clinical trial. Lancet 1996;348:633-8.
10. 10 Sandercock PAG, van der Belt AGM, Lindley RI, Slattery J. Antithrombotic theraphy in acute ischaemic stroke: an overview of the completed randomised trials. J Neurol Neurosurg Psychiatry 1993;56:17-25.
11. 11 Cerebral Embolism Study Group. Immediate anticoagulation of embolic stroke: a randomized trial. Stroke 1983;14:668-76.
12. 12 Vaitkus PT, Berlin JA, Schwartz JS, Barnathan ES. Stroke complicating acute myocardial infarction. A meta-analysis of risk modification by anticoagulation and thrombolytic therapy. Arch Intern Med 1992;152:2020-4.
13. 13 Mohr JP, the WARSS Group. Design considerations for the warfarin-antiplatelet recurrent stroke study. Cerebrovasc Dis 1995;5:156-7.
14. 14 Kay R, Wong KA, Yu YL, Chan YW, Tsoi TH, Ahuja AT, et al. Low-molecular-weight heparin for the treatment of acute ischemic stroke. N Engl J Med 1995;333:1588-93.
15. 15 International Stroke Trial Collaborative Group. The international stroke trial (IST): a randomized trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. Lancet 1997;349:1569-81.
16. 16 Publications Committee for the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators. Low molecular weight heparinoid, ORG 10172 (danaparoid), and outcome after acute ischemic stroke JAMA 1998;279:1265-72.
17. 17 Prevention in Reversible Ischemia Trial (SPIRIT) Study Group. A randomized trial of anticoagulants versus aspirin after cerebral ischemia of presumed arterial origin. Ann Neurol 1997;42:857-65.
18. 18 Diener HC, Cunha L, Forbes C, Sivenius J, Smets P, Lowenthal A. European stroke prevention study 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci 1996;143:1-13.
19. 19 Davis SM, Donnan GA. Secondary prevention for stroke after CAPRIE and ESPS-2. Opinion 1. Cerebrovasc Dis 1998;8:73-5.
20. 20 Dyken ML. Secondary prevention for stroke after CAPRIE and ESPS-2. Opinion 2. Cerebrovasc Dis 1998;8:75-7.
21. 21 Enserink M. Fraud and ethics charges hit stroke drug trial. Science 1996;274:2004-5.
22. 22 Barnett HJM, Eliasziw M, Meldrum HE. Drugs and surgery in the prevention of ischemic stroke. N Engl J Med 1995;332:238-48.
23. 23 Antiplatelet Trialists' Collaborative overview of randomised trials of antiplatelet therapy. I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 1994;308:81-106.
24. 24 Barnett HJM, Eliasziw M, Meldrum HE: Prevention of ischemic stroke [letter]. N Engl J Med 1995;333:460.
25. 25 Bennett CL, Weinberg BS, Rozenberg-Ben-Dror K, Yarnold PR, Kwaan HC, Green D. Thrombotic thrombocytopenic purpura associated with ticlopidine. Ann Intern Med 1998;128:541-4.
26. 26 CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996;348:1329-39.
27. 27 Gorelick PB, Hanley DF. Clopidogrel and its use in stroke patients. Stroke 1998;29:1737.
28. 28 Jonas S, Zeleniuch-Jacquotte A. The effect of antiplatelet agents on survival free of new stroke: a meta-analysis. Stroke Clinical Updates 1998;8:1-4.
29. 29 Eastcott HHG, Pickering GW, Rob CG. Reconstruction of internal carotid artery in a patient with intermittent attacks of hemiplegia. Lancet 1954;2:994-6.
30. 30 Barnett HJM, Plum F, Walton JN. Carotid endarterectomy - an expression of concern. Stroke 1984;15:941-3.
31. 31 European Carotid Surgery Trialists' Group. Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST). Lancet 1998; 351:1379-87.
32. 32 North American Symptomatic Carotid Endarterectomy Trial Collaborators. The benefit of carotid endarterectomy in symptomatic patients with moderate and severe stenosis. N Engl J Med 1998;339:1415-25.
33. 33 North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade stenosis. N Engl J Med 1991;325:445-53.
34. 34 Elmore JR, Franklin DP, Thomas DD, Youkey JR. Carotid endarterectomy: the mandate for high quality duplex. Am Vasc Surg 1998;12:156-62.
35. 35 Executive Committee for the Asymptomatic Carotid Atherosclerosis Study: Endarterectomy for asymptomatic carotid artery stenosis. JAMA 1995;273:1421-8.
36. 36 Hennerici M, Hulsbomer HB, Hefter H, Lammerts D, Rautenberg W. Natural history of asymptomatic extracranial arterial disease. Brain 1987; 110:777-91.
37. 37 Norris JW, Zhu CZ, Bornstein NM, Chambers BR. Vascular risks of asymptomatic carotid stenosis. Stroke 1991;22:1485-90.
38. 38 Biller J, Feinberg WM, Castaldo JE, Whittemore AD, Harbaugh RE, Dempsey RJ, et al. Guidelines for carotid endarterectomy: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 1998;29:554-62.
39. 39 Barnett HJM, Eliasziw M, Meldrum HE, Taylor DW. Do the facts and figures warrant a 10-fold increase in the performance of carotid endarterectomy on asymptomatic patients? Neurology 1996;46:603-8.
40. 40 Warlow C. Endarterectomy for asymptomatic carotid stenosis? Lancet 1995;345:1254-5.
41. 41 Wennberg DE, Lucas FL, Birkmeyer JD, Bredenberg CE, Fisher ES, Variation in carotid endarterectomy mortality in the Medicare population. Trial hospital, volume, and patient characteristics. JAMA 1998;279: 1278-81.
42. 42 Cebul RD, Snow RJ, Pine R, Hertzer NR, Norris DG. Indications, outcomes, and provider volumes for carotid endarterectomy. JAMA 1998;279:1282-7.
43. 43 Kucey DS, Bowyer B, Iron K, Austin P, Anderson G, Tu JV. Determinants of outcome following carotid endarterectomy. J Vasc Surg 1998;28: 1051-8.
44. 44 Hobson RW II, Weiss DG, Fields WS, Goldstone J, Moore WS, Towne JB, et al. Efficacy of carotid endarterectomy for asymptomatic carotid stenosis. N Engl J Med 1993;328:221-7.
45. 45 Chassin MR. Appropriate use of carotid endarterectomy. N Engl J Med 1998;339:1468-71.